Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease. - Wikidata - awgldk - TriplyDB

Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease.

Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease.

http://www.wikidata.org/entity/Q53269268

about

Biomarkers of Alzheimer's disease Cathepsin B is a New Drug Target for Traumatic Brain Injury Therapeutics: Evidence for E64d as a Promising Lead Drug Candidate Biomarkers in Alzheimer's disease analysis by mass spectrometry-based proteomics The cysteine protease inhibitor, E64d, reduces brain amyloid-β and improves memory deficits in Alzheimer's disease animal models by inhibiting cathepsin B, but not BACE1, β-secretase activity Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease Optimization and evaluation of surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry for protein profiling of cerebrospinal fluid.Human body fluid proteome analysis.Cerebrospinal fluid concentration of brain-derived neurotrophic factor and cognitive function in non-demented subjects.In-depth exploration of cerebrospinal fluid by combining peptide ligand library treatment and label-free protein quantification.Multimodal techniques for diagnosis and prognosis of Alzheimer's disease Cerebrospinal fluid biomarkers of Alzheimer's disease.Identification of longitudinally dynamic biomarkers in Alzheimer's disease cerebrospinal fluid by targeted proteomics.Quantitative changes in the mitochondrial proteome from subjects with mild cognitive impairment, early stage, and late stage Alzheimer's disease.Biomarker discovery in neurodegenerative diseases: a proteomic approach.Mass spectrometric analysis of rat cerebrospinal fluid proteins following exposure to the neurotoxicant carbonyl sulfide.Differentially charged isoforms of apolipoprotein E from human blood are potential biomarkers of Alzheimer's disease.Selective identification of newly synthesized proteins in mammalian cells using bioorthogonal noncanonical amino acid tagging (BONCAT)Quantitative label-free proteomics for discovery of biomarkers in cerebrospinal fluid: assessment of technical and inter-individual variation.Quantitative proteomic analysis of oligodendrogliomas with and without 1p/19q deletion UniPep--a database for human N-linked glycosites: a resource for biomarker discovery.Label-free quantitative LC-MS proteomics of Alzheimer's disease and normally aged human brains.F-spondin gene transfer improves memory performance and reduces amyloid-β levels in mice.Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer's disease Translational research in central nervous system drug discovery.Redox proteomics in some age-related neurodegenerative disorders or models thereof Olfactory bulb proteome dynamics during the progression of sporadic Alzheimer's disease: identification of common and distinct olfactory targets across Alzheimer-related co-pathologies.Cathepsin B and cystatin B in HIV-seropositive women are associated with infection and HIV-1-associated neurocognitive disorders.Proteomic analysis of cerebrospinal fluid in amyotrophic lateral sclerosis.Biomarkers for early diagnosis of Alzheimer disease: 'ALZheimer ASsociated gene'--a new blood biomarker?CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases Proteomics of human neurodegenerative diseases Application of mass spectrometry-based proteomics for biomarker discovery in neurological disorders.Unbiased Metabolomic Investigation of Alzheimer's Disease Brain Points to Dysregulation of Mitochondrial Aspartate Metabolism.Alzheimer's disease biomarkers in animal models: closing the translational gap.

P2860

Q24650667-E4AE1D99-8183-4B69-A3DA-816F719FE8C0 Q26782938-96DCF39F-1245-4D19-BC7E-7FC0A7C9878F Q27024518-EFB90893-D63A-437C-95E0-EC373803A9D6 Q28238581-C1A5F8BF-A51C-4B14-8BE4-B2BF9D39EB04 Q28740917-1DB21B07-CFF5-4759-8CCF-6287A69C0886 Q28743561-8F707C47-59BB-4C32-BFFB-76A47AEBD3B9 Q33241392-2C91E2B6-8C51-4D1B-AED6-2FE011F90BE0 Q33262623-2B8CCE9D-B8EF-42B9-9733-E9205D4504FE Q33438465-CA3DADE4-41BB-48DB-AB74-F2848723E8DC Q33525762-FCA1253D-B038-477F-9985-F7CC3C28873F Q33607535-8E57EC17-E6B8-4D6C-B5EE-433E95BBE42C Q33757828-3143684E-0112-489D-8C32-20DA747D7DD6 Q33769278-D1843E28-B8ED-47E7-85B5-B545034B91DC Q34002680-F90EEA5A-8E88-492A-9E33-760EA0F3E233 Q34125681-279575E2-200E-4EF7-B825-DE4899DB7379 Q34453057-3C6110FD-1972-4584-B0EF-E314DA239FF9 Q34629556-5FB77E3F-27BD-45C4-8A36-A25952915823 Q34686995-3A0469E5-AB24-4DF9-8E17-41470560577A Q34735454-325BAD10-E09B-4983-AF6A-6FCBB1D2463F Q35058206-2D7E0C60-672B-43EB-9840-798AA7525162 Q35606070-3DC3763A-A3DC-438F-8A7B-1B2D819307E7 Q36243522-AF6428F7-7909-4DC0-9D27-9FA3CD026F17 Q36317638-B4E9D31D-4ECB-4869-9B2A-C3ECABFD5BBC Q36337525-5BDB2ED7-3794-4B3F-817E-6058F876EBC6 Q36401418-593A794B-07E0-4CF6-B9B8-C814F1B68F07 Q36525171-4DCE673F-C3B7-414B-B068-018ADBAEDC16 Q36545406-DA65938D-4B34-4B71-90C0-484F5DFBC7E2 Q36670527-EE8A9864-6A40-42A8-B8D1-957A381F4A7B Q36953434-2FEEE0D3-574D-4894-B124-9324E1B7DE3D Q37118083-0B153B48-C4C2-42AC-AE39-3194D2C11A6C Q37208032-3ADA9BA0-A6A2-4F38-91CA-33DD8FE75711 Q37260477-07EE94CA-99FD-4933-8252-2F4DBF5C02EA Q37691267-0422CC45-A5F3-4D61-B1A2-8DDF78F3C26D Q38926696-A21C6B98-8DEB-41FE-B8F2-46B3A2A495BD Q41822193-7946A141-1E28-4FC3-958C-E92B1738D394

P2860

Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease.

http://www.wikidata.org/entity/Q53269268

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease.

@en

Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease.

@nl

type

label

Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease.

@en

Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease.

@nl

prefLabel

Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease.

@en

Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease.

@nl

P1433

Q53269268-47A55AA7-AE8C-4EA0-A67C-45509AEC40A3

P1476

Q53269268-E48C7017-2FBF-4AAD-96F6-20F5812A236D

P2093

Q53269268-326ADC7B-5960-4E7D-B0F6-D5FECE3A7B12

Q53269268-33B4C6B2-5C72-4AC5-821A-3EA4A811DD7A

Q53269268-43AEB3C6-2FBA-41EA-B572-9DB2CE50B5F1

Q53269268-5315BD8B-E4DE-466A-AD78-9AEF1550A2A3

Q53269268-5F9EA5B1-27FB-4F08-B776-AC79ECFC193D

Q53269268-6904B5E1-F9C0-4B9D-92EA-ACD02FFBBCC0

Q53269268-6B7D1799-E406-4BF2-A91C-7F12C93BA4B2

Q53269268-858E7332-6403-488C-8304-5FD9CA5A8784

Q53269268-9DBB96FC-E0AA-47A6-BCA8-923F253A5E0B

Q53269268-D3E8289F-4805-4B0A-8D49-EEAE6F7DE852

P304

Q53269268-BCE7A5CA-6C10-4B40-A817-89CC500D7B2A

P31

Q53269268-30716DD9-5608-4C3A-B473-36884342FF50

P433

Q53269268-6C1E946C-AD01-4C02-AA9F-9EE66C28425E

P478

Q53269268-71981F7A-E320-45DA-B8E1-C346B37510F7

P50

Q53269268-5024900E-DAEB-4724-93A5-9A9DA977E421

P577

Q53269268-8865354D-2882-441B-8418-6A4F81AA1C49

P698

Q53269268-2429B389-8F45-47E4-ACD7-5548D7F5223F

P921

Q53269268-C40ACE0F-B097-46FD-BCDF-4260E71778F1

P1433

Journal of Alzheimer's Disease

P1476

Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease.

@en

P2093

Catherine Pan

http://www.w3.org/2001/XMLSchema#string

Dave R Goodlett

http://www.w3.org/2001/XMLSchema#string

Elaine Peskind

http://www.w3.org/2001/XMLSchema#string

Eugene Yi

http://www.w3.org/2001/XMLSchema#string

Jeffrey A Kaye

http://www.w3.org/2001/XMLSchema#string

Jing Zhang

http://www.w3.org/2001/XMLSchema#string

Joseph F Quinn

http://www.w3.org/2001/XMLSchema#string

Qin Wang

http://www.w3.org/2001/XMLSchema#string

Ruedi H Aebersold

http://www.w3.org/2001/XMLSchema#string

Thomas J Montine

http://www.w3.org/2001/XMLSchema#string

P304

125-33; discussion 173-80

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15851850

http://www.w3.org/2001/XMLSchema#string

P921

cerebrospinal fluid